Spatial Analysis of up to 30 Proteins on FFPE Tumor Biopsies May Inform Patient Treatment Decisions Under the collaboration, pathologists at OHSU intend to design a new GeoMx protein assay with up to ...
SEATTLE, Oct. 04, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced ...
The University of Texas MD Anderson Cancer Center and NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced a ...
Seattle's NanoString Technologies ($NSTG) and Harvard University-affiliated Brigham and Women's Hospital in Boston will work together on a new medical diagnostics ...
Premier Access Sites to Offer the Cancer Transcriptome Atlas Service from Labs Across the Globe SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life ...
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the appointment of Dale R. Levitzke as ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability ...
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced it ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the appointment of two new ...
Dr. J. Wayne Cowens, the chief medical officer at Seattle-based NanoString Technologies, has died at the age of 67. “We are shocked and deeply saddened by the sudden loss of our friend and colleague.
Exclusive license to PAM50 signature will be used for patient stratification and prognostic assay. BioClassifier has granted NanoString Technologies an exclusive worldwide license to develop in vitro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results